1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pharvaris NV (PHVS)

  7. Pharvaris NV (PHVS) Financials

PHVS

Pharvaris NV
7.60
0.27 (3.68%)
Upgrade to Real-Time

Pharvaris N.V. (PHVS) Fundamentals
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
SHARE INFORMATION
Market Cap$ 247,664,134
Shares Outstanding33,787,740
Float26,929,954
Percent Float79.7%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.60
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions9
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months2,515
Institutional Holdings Percent11.0%
Institutional Sold Previous 3 Months364,473
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 27.50
52 Week Low$ 1.77
52 Week High Change$ -59.41
21 Day Moving Average$ 7.5195
21 Day Extended Moving Average$ 7.6011
50 Day Moving Average$ 8.436
50 Day Extended Moving Average$ 7.9895
200 Day Moving Average$ 10.6631
200 Day Extended Moving Average$ 10.1519
10 Day Average Volume17,159
20 Day Average Volume20,645
30 Day Average Volume32,512
50 Day Average Volume32,916
Alpha0.095795
Beta-4.6328
Standard Deviation0.926784
R20.077219
7 Day Price Change$ 0.56
7 Day Percent Change8.27%
21 Day Price Change$ 0.16
21 Day Percent Change2.23%
30 Day Price Change$ -0.765
30 Day Percent Change-9.45%
Month to Date Price Change$ -0.765
Month to Date Percent Change-9.45%
Quarter to Date Price Change$ -3.92
Quarter to Date Percent Change-34.84%
180 Day Price Change$ -0.34
180 Day Percent Change-4.43%
200 Day Price Change$ -1.99
200 Day Percent Change-21.31%
Year to Date Price Change$ -3.92
Year to Date Percent Change-34.84%

Pharvaris N.V. (PHVS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.50
Total Debt To Equity0.00
Int Coverage-796.10
Current Ratio11.40
Leverage Ratio1.10
Quick Ratio11.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-5.00
Enterprise Value$ 51,136,270
Price to Sales0.00
Price to Free Cash-5.80
PE High Last 5 Years0.00
Price To Book1.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-21.22
Return on Equity-22.51
Return on Capital-24.67

Pharvaris N.V. (PHVS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers Accountants N.V.
CEOBerndt Modig
Emplyoees56
Last AuditUQ
CIK0001830487
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
AddressJ.H. Oortweg 21
Leiden, 2333 CH
Websitehttps://www.pharvaris.com
Facsimile-
Telephone+31 712036410
Emailinfo@pharvaris.com
Your Recent History
NASDAQ
PHVS
Pharvaris ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230331 19:00:21